Acarbose is a competitive inhibitor of mammalian lysosomal acid α-d-glucosidases

Intraperitoneal injections (∼400 mg/kg of body weight) of acarbose, an inhibitor of acid (1→4)-α-d-glucosidase, perturb the metabolism of glycogen in the liver, resulting in excess storage of lysosomal glycogen. The metabolism of skeletal muscle glycogen was unaffected, suggesting that acarbose either does not enter the tissue or that the muscle α-d-glucosidase is not inhibited. The hydrolysis of maltose and glycogen by the acid α-d-glucosidases from rat liver, rat skeletal muscle, and human placenta was inhibited competitively by acarbose. Thus, the lack of effect of acarbose upon the metabolism of muscle glycogen is due to its inability to enter the tissue.